百洋医药：8月14日召开董事会会议

Group 1 - The core point of the article is that Baiyang Pharmaceutical announced the convening of its third board meeting via remote voting on August 14, 2025, to review various proposals, including the signing of agreements [2] - For the fiscal year 2024, Baiyang Pharmaceutical's revenue composition is as follows: sales of pharmaceuticals and medical devices account for 92.5%, brand services account for 7.18%, and other businesses account for 0.32% [2]